Study directory

Depression studies

Compare studies and check their requirements with the research team.

6115studies shown

Showing 3,313-3,324 of 6,115

TerminatedEUCTR 2006-005578-39

A randomised, double-blind, placebo-controlled study to explore the antidepressant properties of the P38a kinase inhibitor GW856553X 15mg compared to placebo in subjects with Major Depressive Disor...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Estonia

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Estonia
Sponsor: GlaxoSmithKline
Condition: Depression

View study

CompletedEUCTR 2013-002228-18

A randomized controlled clinical trial for assessing the effectiveness of pharmacogenetic information obtained with NEUROFARMAGEN in the treatment of patients with mental disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain

Why is this study shown?

This study is directly about Depression.

Depression, OCD, ...Drug

Countries: Spain
Sponsor: AB-BIOTICS S.A.
Condition: Depression, OCD, ...

View study

CompletedEUCTR 2019-002992-33

A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared Wit...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: France, Belgium, Austria, ...
Sponsor: Janssen-Cilag International NV
Condition: Depression

View study

CompletedEUCTR 2006-001529-24

Adults adminstered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects wit...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: France, United Kingdom, Austria, ...
Sponsor: Sepracor NV in care of Sepracor Inc.
Condition: Depression

View study

CompletedEUCTR 2007-003159-36

An eight-week, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of saredutant 100 mg once daily in combination with escitalopram 10 mg once daily in patient...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: France, Finland, Sweden
Sponsor: sanofi-aventis recherche & développement
Condition: Depression

View study

CompletedEUCTR 2008-001718-26

An eight-week, multicenter, randomized, double-blind, placebo-controlled dose-finding study, with escitalopram (10mg daily) as active control, to evaluate the efficacy, safety and tolerability of t...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Slovakia

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Slovakia
Sponsor: Sanofi-Aventis Recherche & Développement
Condition: Depression

View study

CompletedEUCTR 2014-000230-34

An interventional, randomised, double-blind, parallel-group, placebo-controlled, active-referenced (paroxetine), fixed-dose study on the efficacy of vortioxetine on cognitive dysfunction in working...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Estonia

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Estonia, Finland, Germany, ...
Sponsor: H. Lundbeck A/S
Condition: Depression

View study

CompletedEUCTR 2017-004030-28

Cognition and weight gain during antidepressant treatment.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Denmark
Sponsor: Psychiatric Research Unit
Condition: Depression

View study

CompletedEUCTR 2005-002388-95

Efficacy of agomelatine (25 to 50 mg/day) given orally on quality of remission in elderly depressed patients, after a 12-week treatment period.A randomised, double-blind, flexible-dose internationa...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Belgium, Denmark, Hungary, ...
Sponsor: Institut de Recherches Internationales Servier [...] 1. Institut de Recherches Internationales Servier 2. Laboratorios Servier S.L. (For Spain only)
Condition: Depression

View study

CompletedEUCTR 2013-003370-27

Functional MRI (fMRI) after challenge and treatment with antidepressants and their relation to the clinical course, to the Hypothalamus-Hypophysis-Adrenocortical Axis and the colon microbiome

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: Germany
Sponsor: Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum
Condition: Depression

View study

TerminatedEUCTR 2012-001361-32

Interventional, randomised, double-blind, parallel-group, placebo-controlled, fixed-dose study to evaluate the efficacy and safety of brexpiprazole (1 and 3 mg/day) as adjunctive treatment in el...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria

Why is this study shown?

This study is directly about Depression.

DepressionDrug

Countries: United Kingdom, Bulgaria, Estonia, ...
Sponsor: H. Lundbeck A/S
Condition: Depression

View study

CompletedEUCTR 2011-004860-31

Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria

Why is this study shown?

This study is directly about Depression.

Depression, AnxietyDrug

Countries: Austria
Sponsor: Medical University of Vienna
Condition: Depression, Anxiety

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.